Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
TB 402
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
TB-402 is a long-acting monoclonal antibody that partially inhibits factor VIII. A single administration of TB-402 was effective… Expand
2012
2012
Summary. Background: TB‐402 is a partially inhibiting antibody of factor VIII that is under development as a long‐acting… Expand
2012
2012
INTRODUCTION
Partial inhibition of Factor VIII (FVIII) may provide antithrombotic efficacy whilst avoiding excessive… Expand
2011
2011
Summary. Background: TB‐402 is a novel anticoagulant monoclonal antibody with a prolonged antithrombotic effect resulting from… Expand
Review
2011
Review
2011
The therapeutic armamentarium of parenteral anticoagulants available to clinicians is mainly composed by unfractionated heparin… Expand
2010
2010
BACKGROUND
TB-402, a human monoclonal antibody that partially inhibits Factor VIII activity (FVIII:C), is being developed as a… Expand
2010
2010
Total VTE was lower in each of the TB-402 groups compared to the enoxaparin group: 16.7% (9.8-26.9), 23.9% (15.3-35.3), 24.1%(16… Expand